Skip to main content

View full-text article in PMC

. 2017 Mar 7;8(15):25433–25441. doi: 10.18632/oncotarget.15989

Table 2. Univariate survival analysis according to Kaplan-Meier method and the Logrank test.

Variable	Disease-Free Survival			Progression-Free Survival
	OverallPopulation67 pts	BCG	No BCG	OverallPopulation63 pts	BCG	No BCG
	OverallPopulation67 pts	34 pts	33 pts	OverallPopulation63 pts	33 pts	30 pts
Male vs. Female	0.3400	0.3430	0.5647	0.3355	0.1887	0.9311
Primary vs. Recurrent	0.1926	0.5363	0.1614	0.6409	0.0519	0.2591
Single vs. Multiple	0.4756	0.7956	0.2035	0.6412	0.8857	0.3905
Size <3cm vs. >3cm	0.3926	0.2524	0.7226	0.7417	0.2783	0.4515
HER-2 negative vs. HER-2 positive	0.0013	0.0140	0.0125	0.0322	0.1290	0.1696